申请人:TAKARA BIO INC.
公开号:EP1535891A1
公开(公告)日:2005-06-01
The present invention relates to a therapeutic agent or prophylactic agent for a disease requiring enhancement of nerve growth factor (NGF) production upon treatment or prevention, an enhancing agent for nerve growth factor production, and a food, beverage or feed for enhancing nerve growth factor production, characterized in that each comprises as an effective ingredient a compound selected from the group consisting of soyasaponin compounds, soyasapogenin compounds, glycyrrhizin and salts thereof. In addition, the present invention relates to a novel soyasaponin compound and a novel soyasapogenin compound, having an action for enhancement of NGF production.
本发明涉及一种用于治疗或预防需要增强神经生长因子(NGF)产生的疾病的治疗剂或预防剂,一种增强神经生长因子产生的制剂,以及一种增强神经生长因子产生的食品、饮料或饲料,其特征在于每种制剂都包含一种选自大豆皂苷化合物、大豆皂苷化合物、甘草苷及其盐类的化合物作为有效成分。此外,本发明还涉及一种新型大豆皂苷化合物和一种新型大豆皂苷化合物,它们具有促进神经生长因子产生的作用。